clinicalRSVP raises the bar for study data integrity and participant safety

•    Authenticate Protocol Compliance and Reinforce Study Data Validity.

  By objectively authenticating a participant’s inclusion/exclusion criteria related to previous study participation, researchers can better rely on the results of their study data. More reliable, protocol-compliant study data enables sponsors to make informed decisions and drive progress more effectively and efficiently.

•    Strengthen Participant Safety.

  clinicalRSVP protects subjects from receiving unregulated combinations of investigational medications.

•    Mitigate Risk of Unwarranted Serious Adverse Events.

  Serious adverse events can cripple the development of a valid compound. clinicalRSVP safeguards against the possibility of an erroneous adverse event caused by dual enrollment.

•    Support Adherence to Development Timelines.

  Studies that cannot be completed on time due to the discovery of a dual enroller leads to incomplete study results, forcing additional costs on sites and sponsors. Investigators employing clinicalRSVP can avoid this risk by excluding participants who could compromise results.

•    Improve Screening Accuracy and Efficiency.

  Enhanced access to subject eligibility data during pre-screening can help investigators eliminate ineligible participants prior to spending valuable time and resources on costly screening procedures.